Helicos Slashes Instrument Price by 25 Percent, Obtains Order from the University of Maryland

In terms of attracting new customers, Helicos will "at least initially" narrow its focus on cancer centers, according to recently appointed CEO Lowy.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.